Urothelial papilloma
Urothelial papilloma is a rare, benign tumor that originates in the urinary bladder's urothelial cells. It is characterized by a fibrovascular core covered by normal-appearing urothelial cells.
Epidemiology[edit | edit source]
Urothelial papilloma is a rare condition, accounting for less than 1% of all urinary bladder tumors. It is more common in males than in females and typically occurs in the fifth to sixth decade of life.
Pathology[edit | edit source]
Urothelial papilloma is characterized by a fibrovascular core covered by normal-appearing urothelial cells. The urothelial cells are uniform in size and shape, with no significant nuclear atypia or mitotic activity. The underlying stroma may show mild inflammation.
Clinical Presentation[edit | edit source]
Patients with urothelial papilloma typically present with hematuria, which is often microscopic. Other symptoms may include urinary frequency, urgency, and dysuria. However, many patients are asymptomatic, and the tumor is discovered incidentally during imaging studies for other conditions.
Diagnosis[edit | edit source]
The diagnosis of urothelial papilloma is made by cystoscopy and biopsy. The tumor appears as a small, solitary, papillary lesion on cystoscopy. Histologically, the tumor is characterized by a fibrovascular core covered by normal-appearing urothelial cells.
Treatment[edit | edit source]
The treatment of choice for urothelial papilloma is transurethral resection. This procedure involves the removal of the tumor using a resectoscope inserted through the urethra. Following resection, patients are typically followed with periodic cystoscopy to monitor for recurrence.
Prognosis[edit | edit source]
The prognosis for patients with urothelial papilloma is generally excellent. The tumor is benign and does not invade the bladder wall or metastasize to other sites. However, there is a risk of recurrence, and some patients may develop urothelial carcinoma in situ or invasive urothelial carcinoma.
Urothelial papilloma Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD